CNCR vs. FMED ETF Comparison

Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to Fidelity Disruptive Medicine ETF (FMED)
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$13.22

Average Daily Volume

3,744

Number of Holdings *

67

* may have additional holdings in another (foreign) market
FMED

Fidelity Disruptive Medicine ETF

FMED Description The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$25.24

Average Daily Volume

4,772

Number of Holdings *

52

* may have additional holdings in another (foreign) market
Performance
Period CNCR FMED
30 Days -13.14% -3.41%
60 Days -15.74% -4.25%
90 Days -11.75% -2.27%
12 Months 25.96% 17.18%
7 Overlapping Holdings
Symbol Grade Weight in CNCR Weight in FMED Overlap
ACLX C 1.73% 0.45% 0.45%
BNTX C 1.25% 0.4% 0.4%
DAWN D 1.44% 0.41% 0.41%
JANX C 1.46% 1.32% 1.32%
LEGN D 1.1% 1.95% 1.1%
NRIX C 1.29% 0.44% 0.44%
REGN F 1.0% 3.26% 1.0%
CNCR Overweight 60 Positions Relative to FMED
Symbol Grade Weight
GLUE C 2.03%
EXEL B 1.9%
RVMD C 1.84%
BMY B 1.72%
ELVN D 1.68%
XNCR B 1.66%
MRSN D 1.62%
BPMC B 1.58%
KPTI D 1.57%
REPL D 1.56%
GNLX F 1.56%
MGNX F 1.55%
HCM D 1.54%
SWTX C 1.47%
CRBU D 1.47%
ERAS C 1.46%
IMCR D 1.42%
RXRX F 1.39%
SDGR C 1.39%
ARVN F 1.39%
AURA C 1.38%
LYEL F 1.35%
SNDX F 1.34%
MRUS F 1.33%
KYMR D 1.32%
RPTX F 1.32%
GERN D 1.31%
IOVA F 1.3%
RCUS F 1.29%
FHTX C 1.26%
NUVB C 1.26%
ZNTL F 1.25%
MRK D 1.24%
BCYC F 1.24%
YMAB F 1.24%
BMEA F 1.22%
PGEN F 1.2%
CGEM F 1.2%
ALLO F 1.18%
NUVL C 1.18%
VOR D 1.17%
GMAB F 1.17%
TYRA F 1.16%
KURA F 1.16%
ACRV F 1.15%
AUTL F 1.13%
STRO F 1.12%
IDYA F 1.07%
TSVT F 1.06%
ITOS F 0.98%
IPHA D 0.98%
SMMT D 0.97%
ACET F 0.97%
IMRX F 0.95%
IMTX F 0.93%
RLAY F 0.91%
IGMS F 0.88%
RAPT F 0.88%
FATE F 0.87%
PRLD F 0.55%
CNCR Underweight 45 Positions Relative to FMED
Symbol Grade Weight
BSX A -6.26%
UNH B -4.7%
PODD C -4.44%
ISRG A -4.42%
DHR F -3.8%
ARGX B -3.27%
ALNY D -2.9%
SYK B -2.73%
EXAS D -2.72%
PEN B -2.64%
LFST B -2.41%
VEEV C -2.18%
MASI B -2.01%
EW C -1.95%
INSP D -1.92%
DXCM C -1.88%
TMO F -1.87%
LLY F -1.78%
PRCT B -1.65%
ZLAB C -1.54%
AGL F -1.43%
GKOS B -1.42%
RGEN D -1.34%
PRVA C -1.34%
KROS D -1.34%
RMD C -1.3%
CRNX C -1.23%
CYTK F -1.19%
XENE D -1.17%
DOCS C -1.14%
DYN F -1.13%
PCVX D -1.13%
BRKR D -1.12%
WST C -1.01%
TNDM D -1.0%
PHR F -0.99%
CNC D -0.98%
ASND F -0.88%
VRTX D -0.84%
ALGN D -0.72%
TXG F -0.63%
NTRA A -0.56%
DNLI D -0.45%
IRTC C -0.44%
ANAB F -0.24%
Compare ETFs